Related Experiment Video
Updated: Oct 12, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
779
NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy
Adriana Gutiérrez-Hoya1,2, Isabel Soto-Cruz1
1Molecular Oncology Laboratory, Cell Differentiation and Cancer Research Unit, FES Zaragoza, National University of Mexico, Batalla 5 de Mayo S/n Col. Ejército de Oriente, Mexico City 09230, Mexico.
Cells
|November 27, 2021
Summary
Natural killer (NK) cells are crucial for fighting cervical cancer by targeting virus-infected cells and tumors. Harnessing NK cells through immunotherapy offers a promising strategy to combat this prevalent gynecological malignancy.
Area of Science:
- Immunology
- Oncology
- Gynaecology
Background:
- Cervical cancer is a major global gynecological malignancy linked to human papillomavirus (HPV) infection.
- The immune response, particularly involving Natural Killer (NK) cells, is critical in managing HPV infection and tumor progression.
- NK cells are vital for immunosurveillance against virus-infected cells and tumors.
Purpose of the Study:
- To review recent advancements in utilizing NK cells for cervical cancer prevention and treatment.
- To explore the potential of NK cell-based immunotherapy as a leading strategy against cervical tumors.
Main Methods:
- Review of current research on NK cell applications in cervical cancer immunotherapy.
- Discussion of strategies involving activated NK cell transfer, cytokine-enhanced NK cell activity, and chimeric antigen receptor (CAR)-NK cell modifications.
Main Results:
- Growing interest exists in leveraging NK cells for cervical cancer immunotherapy.
- Diverse strategies are being investigated, including adoptive transfer and engineered NK cells.
- Research in this area, while promising, remains limited.
Conclusions:
- NK cells play a central role in the immune response to HPV and cervical cancer.
- NK cell-based immunotherapy presents a potential breakthrough strategy for treating cervical cancer.
- Further research is needed to fully realize the therapeutic potential of NK cells in managing this disease.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
725
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
01:27Cytotoxic T Cells-mediated Immune Response
4.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
01:30Cancer Vaccines
556
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
556
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K